MORGAN STANLEY - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$157,941
+0.7%
60,514
+38.2%
0.00%
Q2 2023$156,768
-74.7%
43,790
-84.6%
0.00%
Q1 2023$619,417
-83.7%
284,136
-10.2%
0.00%
Q4 2022$3,806,183
+11.4%
316,391
-40.0%
0.00%
Q3 2022$3,416,000
+8.6%
527,106
-23.3%
0.00%
Q2 2022$3,145,000
-38.8%
686,851
+15.6%
0.00%
-100.0%
Q1 2022$5,139,000
-6.9%
594,028
+53.6%
0.00%0.0%
Q4 2021$5,520,000
+109.3%
386,620
+222.2%
0.00%
Q3 2021$2,637,000
+138.2%
120,005
+45.2%
0.00%
Q2 2021$1,107,000
+708.0%
82,666
+514.3%
0.00%
Q1 2021$137,000
+291.4%
13,456
+63.8%
0.00%
Q4 2020$35,000
+133.3%
8,216
+43.1%
0.00%
Q3 2020$15,000
-34.8%
5,741
-12.9%
0.00%
Q2 2020$23,000
+21.1%
6,595
+2.5%
0.00%
Q1 2020$19,000
-84.2%
6,436
-72.2%
0.00%
Q4 2019$120,000
+22.4%
23,175
-24.7%
0.00%
Q3 2019$98,000
-3.0%
30,797
+9.0%
0.00%
Q2 2019$101,000
+4.1%
28,252
+5.8%
0.00%
Q1 2019$97,000
+14.1%
26,701
-6.0%
0.00%
Q4 2018$85,000
-40.6%
28,394
-3.5%
0.00%
Q3 2018$143,000
-34.7%
29,434
-0.0%
0.00%
Q2 2018$219,000
-0.5%
29,439
-13.1%
0.00%
Q1 2018$220,000
-32.1%
33,887
-5.9%
0.00%
Q4 2017$324,000
+120.4%
35,994
+143.8%
0.00%
Q3 2017$147,000
+50.0%
14,766
+16.9%
0.00%
Q2 2017$98,000
-38.8%
12,635
-51.5%
0.00%
Q1 2017$160,000
-17.5%
26,064
-17.8%
0.00%
Q4 2016$194,000
+65.8%
31,720
+97.8%
0.00%
Q3 2016$117,000
-63.6%
16,039
-58.3%
0.00%
Q2 2016$321,000
+1184.0%
38,492
+910.6%
0.00%
Q1 2016$25,000
-10.7%
3,809
+15.1%
0.00%
Q4 2015$28,000
-6.7%
3,309
-40.9%
0.00%
Q3 2015$30,000
+15.4%
5,595
+23.7%
0.00%
Q2 2015$26,000
+8.3%
4,522
+21.6%
0.00%
Q1 2015$24,000
-33.3%
3,718
-52.5%
0.00%
Q4 2014$36,000
-51.4%
7,823
-15.1%
0.00%
Q3 2014$74,000
-42.6%
9,215
-31.1%
0.00%
Q2 2014$129,000
-58.4%
13,373
-49.1%
0.00%
Q1 2014$310,000
+68.5%
26,297
+120.2%
0.00%
Q4 2013$184,00011,9410.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders